Karch Focus on Nursing Pharmacology Chapter 1
Question with complete Solutions New update
2026 Grade A+
QUESTIONS AND ANSWERS
Adverse Effects. ANSWER - drugs effects that are not to the desired therapeutic affects;
may be unpleasant or even dangerous
Brand Name. ANSWER - name given to a drug the pharmaceutical company that
developed it; also called a trade name
Chemical Name. ANSWER - name that reflects the chemical structure of a drug
Drugs. ANSWER - chemicals that are introduced into the body to bring about some sort of
change
FDA. ANSWER - federal agency responsible for the regulation and enforcement of drug
evaluation and distribution policies
Generic Drugs. ANSWER - drugs sold by their chemical name, not brand or trade name
products
Generic Name. ANSWER - the original designation that a drug is given when the drug
company that develops it applies for the approval process
Genetic Engineering. ANSWER - process of altering DNA, usually of bacteria, to produce
a chemical to be used as a drug
Orphan Drugs. ANSWER - drugs that have been discovered but would not be profitable
for a drug company to develop; usually drugs that would treat only a small number of
people; these orphans can be adopted by drug companies to be developed
, Over the Counter OTC. ANSWER - available without a prescription for self treatment of a
variety of complaints, deemed to be safe if used as directed
Pharmacology. ANSWER - the study of the biological effects of chemicals
Pharmacotherapeutics. ANSWER - clinical pharmacology-the branch of pharmacology that
deals with drugs; chemicals that care used in medicine for the treatment, prevention and
diagnosis of disease in humans
Steps involved in developing/approving new drug in the U.S. ANSWER - *preclinical
*Phase I, II and III studies
*Once finish phase III evaluated by FDA
*Approved drug given brand name
*Phase IV continual evaluation
PreClinical Trials. ANSWER - Chemicals tested on lab animals
Phase One Study. ANSWER - Chemicals tested human volunteers for several months
Dropped If: too toxic, unacceptable adverse reactions, lack therapeutic effect in humans
Phase Two Study. ANSWER - Drug tried on informed pt's
Dropped if: less effective than anticipated, too toxic, low benefit-to-risk ratio
Phase Three Study. ANSWER - drug used in vast clinical market for those who have the
disesase
Dropped if: unacceptable adverse effects/unforeseen reactions
Question with complete Solutions New update
2026 Grade A+
QUESTIONS AND ANSWERS
Adverse Effects. ANSWER - drugs effects that are not to the desired therapeutic affects;
may be unpleasant or even dangerous
Brand Name. ANSWER - name given to a drug the pharmaceutical company that
developed it; also called a trade name
Chemical Name. ANSWER - name that reflects the chemical structure of a drug
Drugs. ANSWER - chemicals that are introduced into the body to bring about some sort of
change
FDA. ANSWER - federal agency responsible for the regulation and enforcement of drug
evaluation and distribution policies
Generic Drugs. ANSWER - drugs sold by their chemical name, not brand or trade name
products
Generic Name. ANSWER - the original designation that a drug is given when the drug
company that develops it applies for the approval process
Genetic Engineering. ANSWER - process of altering DNA, usually of bacteria, to produce
a chemical to be used as a drug
Orphan Drugs. ANSWER - drugs that have been discovered but would not be profitable
for a drug company to develop; usually drugs that would treat only a small number of
people; these orphans can be adopted by drug companies to be developed
, Over the Counter OTC. ANSWER - available without a prescription for self treatment of a
variety of complaints, deemed to be safe if used as directed
Pharmacology. ANSWER - the study of the biological effects of chemicals
Pharmacotherapeutics. ANSWER - clinical pharmacology-the branch of pharmacology that
deals with drugs; chemicals that care used in medicine for the treatment, prevention and
diagnosis of disease in humans
Steps involved in developing/approving new drug in the U.S. ANSWER - *preclinical
*Phase I, II and III studies
*Once finish phase III evaluated by FDA
*Approved drug given brand name
*Phase IV continual evaluation
PreClinical Trials. ANSWER - Chemicals tested on lab animals
Phase One Study. ANSWER - Chemicals tested human volunteers for several months
Dropped If: too toxic, unacceptable adverse reactions, lack therapeutic effect in humans
Phase Two Study. ANSWER - Drug tried on informed pt's
Dropped if: less effective than anticipated, too toxic, low benefit-to-risk ratio
Phase Three Study. ANSWER - drug used in vast clinical market for those who have the
disesase
Dropped if: unacceptable adverse effects/unforeseen reactions
